The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. Johnson (Q40508720)

21 September 2017

title

The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. Johnson (English)

1 reference

21 September 2017

6

Peter A Calabresi

1 reference

21 September 2017

4

Howard Weiner

1 reference

21 September 2017

9

Teresa C Frohman

1 reference

21 September 2017

Eric J Kildebeck

1

1 reference

21 September 2017

Ram Narayan

2

1 reference

21 September 2017

Avindra Nath

3

1 reference

21 September 2017

Shin Beh

5

1 reference

21 September 2017

Lawrence Steinman

7

1 reference

21 September 2017

Eugene O Major

8

1 reference

21 September 2017

Elliot M Frohman

10

1 reference

21 September 2017

language of work or name

1 reference

12 October 2016

1 reference

21 September 2017

1 reference

21 September 2017

volume

264

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

817-828

1 reference

THE EFFECTS OF EXPERIMENTAL DEMYELINATION ON CONDUCTION IN PERIPHERAL NERVE: A HISTOLOGICAL AND ELECTROPHYSIOLOGICAL STUDY. II. ELECTROPHYSIOLOGICAL OBSERVATIONS

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Visual evoked response in diagnosis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

THE ANTIBODY RESPONSE OF RABBITS TO INJECTIONS OF EMULSIONS AND EXTRACTS OF HOMOLOGOUS BRAIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Astrocytes and intracerebral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Pathogenesis of viral infections of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

An Epidemiologic Approach to Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Environmental factors and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The worldwide prevalence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Sexual disparities in the incidence and course of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Familial risk of multiple sclerosis: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Multiple sclerosis in the faroe islands: I. Clinical and epidemiological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Multiple sclerosis in the Faroe Islands: an epitome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epidemiologic evidence for multiple sclerosis as an infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epidemiology in multiple sclerosis: a pilgrim's progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Viral infections and demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

21 January 2018

Slow Viral Infections

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The virology of demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

HIV-related neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Measles Encephalomyelitis — Clinical and Immunologic Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Hay fever, hygiene, and household size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Minireview: vitamin D receptor: new assignments for an already busy receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Human regulatory T cells and their role in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local injection of ethidium bromide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Review: the role of vitamin D in nervous system health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Primary infection with the Epstein-Barr virus and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epstein-Barr virus and multiple sclerosis: interaction with HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Twin concordance and sibling recurrence rates in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The genetics of multiple sclerosis: an up-to-date review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

HLA-DR15 haplotype and multiple sclerosis: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The inheritance of resistance alleles in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Epigenetic changes in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The epigenetics of multiple sclerosis and other related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Timing of birth and risk of multiple sclerosis: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Confounding underlies the apparent month of birth effect in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

1,25-Dihydroxyvitamin D3Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Smoking and multiple sclerosis: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Smoking and disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Cigarette smoking and the progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Cigarette smoking and DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Body size and risk of MS in two cohorts of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Obesity and susceptibility to autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Individuality and epigenetics in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

The role of epigenetic mechanisms and processes in autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Maternal Transmission of Multiple Sclerosis in a Dutch Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

Effect of Demyelination on Conduction in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8293-Y

A new scale for evaluating disability in multiple sclerosis

21 January 2018

1 reference

12 December 2020

A method for estimating the age at immigration of white immigrants to South Africa, with an example of its importance

1 reference

12 December 2020

The effects of isoniazid on patients with multiple sclerosis; preliminary report.

1 reference

12 December 2020

Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection.

1 reference

12 December 2020

Genetics of multiple sclerosis

1 reference

12 December 2020

A population-based study of multiple sclerosis in twins

1 reference

12 December 2020

A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases

1 reference

12 December 2020

Essentials for starting a pediatric clinical study (2): Role of environment and immunity in the development of childhood allergic and immunologic disorders.

1 reference

12 December 2020

Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies

1 reference

12 December 2020

Multiple sclerosis in North African migrants to France.

1 reference

12 December 2020

Viking voyages: the origin of multiple sclerosis?: An essay in medical history

1 reference

12 December 2020

MULTIPLE SCLEROSIS AND POLIOMYELITIS

1 reference

12 December 2020

An evaluation of the geographic distribution of multiple sclerosis

1 reference

12 December 2020

The neurobiology of human immunodeficiency virus infections

1 reference

12 December 2020

Multiple sclerosis in time and space--geographic clues to cause

1 reference

12 December 2020

ISONIAZID in treatment of multiple sclerosis; report on Veterans Administration cooperative study

1 reference

12 December 2020

The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins

1 reference

12 December 2020

10.1007/S00415-016-8293-Y

Identifiers

DOI

1 reference

21 September 2017

1 reference